Summary
Cardinal Health Inc. reported record revenue of $81.4 billion for the fiscal year ended June 30, 2006, a 10% increase year-over-year, driven by growth across all four reportable segments. The company highlighted an 8% increase in operating earnings to $2.0 billion and a 14% rise in diluted earnings per share from continuing operations to $2.90. A significant transition to a fee-for-service model in the Pharmaceutical Distribution segment was completed, which is expected to moderate earnings seasonality and volatility. However, the company is also managing the impact of ongoing SEC and U.S. Attorney investigations, for which it has reserved $35 million, and significant shareholder litigation, though the ultimate outcome and financial impact are currently unpredictable. Despite these legal and regulatory challenges, the company continues to focus on operational improvements and strategic acquisitions, demonstrating resilience in its core distribution and services businesses.
Key Highlights
- 1Reported record revenue of $81.4 billion for FY 2006, a 10% increase from FY 2005.
- 2Operating earnings grew 8% to $2.0 billion, with diluted EPS from continuing operations up 14% to $2.90.
- 3Completed transition to a fee-for-service model in Pharmaceutical Distribution, aiming to reduce earnings volatility.
- 4Clinical Technologies and Services segment showed strong operating earnings growth of 56% due to revenue increases and efficiencies.
- 5The company is subject to ongoing SEC and U.S. Attorney investigations, with an agreement-in-principle for a potential $35 million settlement with the SEC.
- 6Significant shareholder and ERISA litigation is ongoing, with an uncertain but potentially material impact on future results.
- 7The company announced new share repurchase programs totaling $2 billion to be completed over fiscal years 2007 and 2008.